Skip to main navigation Skip to search Skip to main content

Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms

  • Michael Selgrad*
  • , Jan Bornschein
  • , Arne Kandulski
  • , Carla Hille
  • , Jochen Weigt
  • , Albert Roessner
  • , Thomas Wex
  • , Peter Malfertheiner
  • *Corresponding author for this work
  • Otto von Guericke University Magdeburg
  • Medical Laboratory for Clinical Chemistry

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)

Abstract

Recent studies have suggested that Helicobacter pylori (H. pylori) constitutes a risk for the development of colonic neoplasia. Hypergastrinemia can be induced by H. pylori infection, and gastrin can act as putative promoter of colorectal carcinogenesis. Aim of our study was to assess whether H. pylori infection and/or increased serum gastrin levels are associated with the occurrence of colonic neoplasms. For this, we reviewed prospectively collected data of 377 patients with a minimum age of 50 years who underwent colonoscopy. H. pylori and CagA status were determined by serology. Serum gastrin levels were measured in fasting state by commercially available assay. In H. pylori infected patients (n = 138; 36.6%), the overall prevalence of colonic neoplasms was more frequent compared to H. pylori negative patients (n = 239; 63.4%) (OR = 2.73, 95% CI: 1.76-4.24). H. pylori infection occurred more frequently in patients with hyperplastic polyps (OR = 2.66, 95% CI: 1.23-5.74) and adenomas presenting with low grade intraepithelial neoplasia (IEN) (OR = 1.85, 95% CI: 1.14-2.99). Attributable risk for adenomas with high grade IEN and colorectal adenocarcinoma (n = 14) was not assessed due to the low number of cases. The expression of CagA was also associated with an increased risk for colonic neoplasms (OR = 2.25, 95% CI: 1.29-3.94). Hypergastrinemia did not increase the risk for any colonic neoplasms and there was no difference in basal serum gastrin levels between H. pylori positive and negative patients. In conclusion, H. pylori infection, including CagA expression is associated with an increased risk for the development of colonic neoplasm. What's new? Though the bacteria H. pylori is best known for its effects on the stomach, evidence has been emerging that it may also contribute to cancer of the colon. In this paper, the authors checked for colonic neoplasms in patients with and without H. pylori infection, paying special attention to strains that express CagA, which are most likely to cause gastric inflammation and cancer. They did indeed find neoplasms more often in the colons of patients who harbored the bacteria, especially those that express CagA. Although the protein gastrin seemed a likely mechanism for spurring these neoplasms, the authors found no increase in serum gastrin levels among the patients with H. pylori infection.

Original languageEnglish
Pages (from-to)1127-1131
Number of pages5
JournalInternational Journal of Cancer
Volume135
Issue number5
DOIs
Publication statusPublished - 1 Sept 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • colonic neoplasms
  • gastrin
  • Helicobacter pylori

Fingerprint

Dive into the research topics of 'Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms'. Together they form a unique fingerprint.

Cite this